Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Stichting Hemato-Oncologie voor Volwassenen Nederland
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Rush University Medical Center
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Stanford University
Teva Branded Pharmaceutical Products R&D, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
Duke University
Children's Oncology Group
GOG Foundation
University of Chicago
Sarcoma Alliance for Research through Collaboration
Amgen